LATEST
Tue, Oct 6, 2026
Loading weather...
Markets

Aligos Therapeutics To Present HBV, HDV Programs At AASLD 2026

(RTTNews) - Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company, announced that five abstracts ...

(RTTNews) - Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company, announced that five abstracts have been accepted for presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2026, being held November 5 - 9, 2026.

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Kenmare Resources Confirms Receiving Non-binding Bid From International Resources

(RTTNews) - Kenmare Resources plc (KMR.L), a manufacturer of mineral sand produc...

Read Article »

Jio IPO: Latest GMP today, launch date, Reliance shareholder quota, expected share price band, size, valuation - Details

Jio Platforms is nearing India's largest IPO, expected to file final documents w...

Read Article »

Firmus Stock Overhang Said to Make Some Investors Wary on IPO

Some potential investors are turning more cautious on the blockbuster initial pu...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.